Ever Fortune. AI Co

Ever Fortune. AI Co Receivables

The Accounts Receivable of Ever Fortune. AI Co (6841.TWO) as of Oct 21, 2026 is 79.72 M TWD. In the previous year, Accounts Receivable was 33.66 M TWD — a change of 136.81% (higher).

Receivables

79.72 MTWD

YoY

136.81%

Last updated:

Accounts Receivable of Ever Fortune. AI Co is 2024 79.72 M TWD. Accounts Receivable of Ever Fortune. AI Co was 2023 33.66 M TWD. It decreases by 136.81% higher compared to the previous year.

The Ever Fortune. AI Co Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2018
58,000.00 TWD
Jan 1, 2019
210,000.00 TWD
Jan 1, 2020
309,000.00 TWD
Jan 1, 2021
1.93 M TWD
Jan 1, 2022
15.75 M TWD
Jan 1, 2023
33.66 M TWD
Jan 1, 2024
79.72 M TWD
The Ever Fortune. AI Co Receivables history
YEARReceivablesYoY
79.72 MTWD+136.81%
33.66 MTWD+113.71%
15.75 MTWD+715.74%
1.93 MTWD+524.92%
309,000.00TWD+47.14%
210,000.00TWD+262.07%
58,000.00TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ever Fortune. AI Co Stock analysis

What does Ever Fortune. AI Co do? Ever Fortune.AI Co., Ltd. generates revenue through the sale of medical AI software products and customized technology solutions. The company offers medical big data platforms, cloud biomedical services, and AI-driven tools such as the radiographic bone age-assisted interpretation system, ultrasound breast tumor auxiliary classification system, and CT liver cancer metastasis risk management system. These products target healthcare providers, hospitals, and medical institutions seeking advanced diagnostic and analytical capabilities. The firm's focus on specialized medical AI applications ensures consistent demand from clients requiring precision in radiology, oncology, and cardiology. The company's revenue streams include the provision of medical AI data analysis services and tailored AI technology solutions for healthcare facilities. Products like the liver fibrosis evaluation system and irregular cardiac fibrillation interpretation system are designed to address specific clinical needs, enhancing diagnostic accuracy. Healthcare organizations, particularly those in radiology and cardiology departments, purchase these tools to improve patient outcomes and operational efficiency. Ever Fortune.AI's business model centers on delivering high-value AI solutions for medical diagnostics, with a portfolio that includes both standardized products and custom-developed systems. The firm's offerings cater to hospitals and medical institutions looking to integrate AI into their diagnostic workflows. By focusing on niche medical applications, the company establishes itself as a specialized provider in the healthcare technology sector. Ever Fortune. AI Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ever Fortune. AI Co stock

Accounts Receivable of Ever Fortune. AI Co is 79.72 M TWD in 2024.

Accounts Receivable of Ever Fortune. AI Co changed from 33.66 M TWD to 79.72 M TWD, representing a 136.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Ever Fortune. AI Co since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Ever Fortune. AI Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Ever Fortune. AI Co

All Key Metrics — Ever Fortune. AI Co